Artelo Biosciences, Inc DEFA14A, filed Jun 22, 2021
Artelo Biosciences, Inc. (ARTL)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|
|
|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) |
|
|
|
| ☐ | Definitive Proxy Statement |
|
|
|
| ☒ | Definitive Additional Materials |
|
|
|
| ☐ | Soliciting Material Pursuant to §240.14a‑11(c) or §240.14a‑2 |
| ARTELO BIOSCIENCES, INC. |
| (Name of Registrant as Specified In Its Charter) |
|
|
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
|
| Payment of Filing Fee (Check the appropriate box): |
|
|
|
| ☒ | No fee required. |
|
|
|
| ☐ | Fee computed on table below per Exchange Act Rules 14a‑6(i)(4) and 0‑11. |
|
| (1) | Title of each class of securities to which transaction applies: |
|
|
|
|
|
| (2) | Aggregate number of securities to which transaction applies: |
|
|
|
|
|
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (Set forth the amount on which the filing fee is calculated and state how it was determined): |
|
|
|
|
|
| (4) | Proposed maximum aggregate value of transaction: |
|
|
|
|
|
| (5) | Total fee paid: |
|
|
|
|
| ☐ | Fee paid previously with preliminary materials. |
|
|
|
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
| (1) | Amount Previously Paid: |
|
|
|
|
|
| (2) | Form, Schedule or Registration Statement No.: |
|
|
|
|
|
| (3) | Filing Party: |
|
|
|
|
|
| (4) | Date Filed: |
|
|
|
|
June 21, 2021
Dear Stockholder,
You recently received proxy materials in connection with the 2021 Annual Meeting of Stockholders of Artelo Biosciences, Inc. that was previously scheduled to be held June 18, 2021. Unfortunately, not enough shares were present at the Annual Meeting to establish a quorum, and we had to adjourn the meeting to July 16, 2021. According to our latest records, your VOTE at the Annual Meeting HAS NOT YET BEEN RECEIVED.
PLEASE VOTE TODAY!
You should refer to the proxy materials previously mailed to you for additional information. If you have not received these materials, please call us immediately so that we can provide you with the materials.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” ALL PROPOSALS
Please vote your shares today so that your vote can be counted without delay. Voting is easy. You may use one of the options below to ensure that your vote is promptly recorded in time for the Annual Meeting:
|
| · | VOTE VIA THE INTERNET: You may cast your vote by following the instructions on the enclosed voting instruction form. |
|
|
|
|
|
| · | VOTE BY PHONE: You may cast your vote by calling the toll-free number on the enclosed voting instruction form. |
If you have any questions or require further assistance in voting your shares, please contact our proxy solicitor Okapi Partners LLC at (212) 297-0720 or toll-free at (877) 566-1922.
YOUR PARTICIPATION IS IMPORTANT - PLEASE VOTE TODAY!
Thank you very much.
We appreciate your support.
| IF YOU HAVE RECENTLY MAILED YOUR PROXY CARD OR CAST YOUR VOTE BY PHONE OR INTERNET, PLEASE ACCEPT OUR THANKS AND DISREGARD THIS REQUEST. |
| 2 |